MBE
ALNY icon

Michael B. Elefante’s Alnylam Pharmaceuticals ALNY Stock Holding History

Michael B. Elefante’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-7,840
Closed -$612K – 110
2014
Q3 		$612K Hold
7,840
– – 0.26% 58
2014
Q2 		$495K Buy
7,840
+150
+2% +$8.92K 0.21% 62
2014
Q1 		$517K Sell
7,690
-7,685
-50% -$595K 0.22% 60
2013
Q4 		$989K Sell
15,375
-1,355
-8% -$80.8K 0.46% 48
2013
Q3 		$1.07M Hold
16,730
– – 0.54% 44
2013
Q2 		$518K Buy
+16,730
New +$445K 0.28% 53

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return